Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Chembio Receives $8.5M Purchase Commitment From Bio-Manguinhos

Chembio Receives $8.5M Purchase Commitment From Bio-Manguinhos

Dec 05, 2017
|
staff reporter

NEW YORK (360Dx) – Chembio Diagnostics said today that it has received a commitment from Bio-Manguinhos for the purchase of $8.5 million worth of materials related to its HIV and Leishmania point-of-care immunoassays.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

What's Popular?

In Infectious Disease

  1. Infectious Disease Test Firm Talis Biomedical Files for IPO

  2. Lab Stakeholders Welcome Biden Moves on COVID-19 Testing, Suggest Additional Steps

    Premium

  3. Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets

    Premium

  4. Rhinostics Licenses Procter & Gamble Nasal Swab for COVID-19 Testing

  5. FIND, Unitaid Ink First Agreement to Enable COVID-19 Antigen Tests at $2.50 Apiece

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.